CRWD · Verdict
More arguments for
A summary of rules, not a profit forecast — don’t buy just because of a green verdict.
🟡 Valuation- ▲ Forward P/E 155.4 is below the current one — earnings growth expected
🟡 Quality- ▼ Share count up 7% in 3 y — your stake is being diluted
- ▼ ROE 1% — weak return on equity
- ▲ Net margin rose: -8.2% → -3.4%
- ▲ Debt / equity 0.19 — moderate debt
- ▲ Free cash flow positive every year
🟡 Growth- ▲ Revenue grows 29.0% per year (3 y)
- ▼ Analysts cut the earnings forecast by -1.9% in 90 days
🟢 Trend- ▲ Over 6 mo stronger than its sector (XLK) by 112%
- ▲ Price above SMA200 — long-term uptrend
- ▲ SMA50 above SMA200 — trend up
- ▲ Over a year +86% vs S&P 500 +11% — stronger than the market
🔴 Risk · context, does not vote- ▼ Volatility 56% per year — much higher than the market (13%)
- ▼ Max drawdown in the period -68% — deep
🟡 Sentiment- ▲ Consensus of 50 analysts — buy
- ▼ Insiders selling over 6 mo
🟢 Market · context, does not vote- ▲ S&P 500 above SMA200 — the market is in an uptrend
- ▲ Sector (XLK) above SMA200 — in an uptrend
The PWA verdict uses less data than the full version: without the history of multiples and peers, F-score, Altman, interest coverage, dividend streak and expected earnings move.